Pubblicati su “The Lancet Oncology” i risultati a lungo termine dello studio italiano ARTO, primo trial randomizzato a ...

Advanced Medical Care at Home Among Patients With Acute Heart Failure 1. Following hospitalization for acute decompensated ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance, today announced ...

Staff from the Institute of Cancer Research (ICR) are taking industrial action over pay, with some claiming they are ‘getting ...

In this long-term follow-up to the phase 2 ARTO trial, researchers analyzed survival outcomes in patients with CRPC treated with metastasis-directed therapy.

A digital pathology multimodal AI test predicted a benefit from adding abiraterone to standard long-term androgen deprivation therapy (ADT) and radiotherapy in very high-risk, nonmetastatic prostate ...

背景：非转移性高危局限期前列腺癌标准治疗为长期雄激素剥夺疗法（Long-Term Androgen Deprivation Therapy, LT-ADT）联合放疗，极高危患者加用阿比特龙（Abiraterone Acetate plus Prednisolo 背景：非转移性高 ...

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen ...

NHS England has given the green light for abiraterone to be used to treat men with prostate cancer that has not metastasised. It is the first time the drug will be available for these patients in ...

Abiraterone plus androgen deprivation therapy (ADT), with prednisolone or prednisone can be used, within its marketing authorisation, as an option to treat newly diagnosed high-risk hormone‑sensitive ...

The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to ...

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH) have shown that a reduced dose of abiraterone ...